[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Pages 54583-54584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25403]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L.109-482) provides organizational 
authorities to HHS and NIH officials to: (1) Establish or abolish 
national research institutes; (2) reorganize the offices within the 
Office of the Director, NIH including adding, removing, or transferring 
the functions of such offices or establishing or terminating such 
offices; and (3) reorganize, divisions, centers, or other 
administrative units within an NIH national research

[[Page 54584]]

institute or national center including adding, removing, or 
transferring the functions of such units, or establishing or 
terminating such units. The purpose of the Scientific Management Review 
Board (also referred to as SMRB or Board) is to advise appropriate HHS 
and NIH officials on the use of these organizational authorities and 
identify the reasons underlying the recommendations.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Scientific Management Review Board.
    Date: November 12-13, 2009.
    Time: November 12, 2009, 1 p.m. to 5 p.m.
    Agenda: Presentation and discussion will include updates from 
SMRB Working Groups: Deliberating Organizational Change and 
Effectiveness; NIH Intramural Research Program; and Substance Use, 
Abuse, and Addiction. There will also be time allotted on the agenda 
for public comment. Sign up for public comment will begin at 
approximately 12 p.m. In the event that time does not allow for all 
those interested to present oral comments, anyone may file written 
comments using the address below.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Time: November 13, 2009, 8:30 a.m. to 12 p.m.
    Agenda: Continuation of November 12th meeting.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Dr. Lyric Jorgenson, PhD, NIH-AAAS Science and 
Technology Policy Fellow, Office of Science Policy, Office of the 
Director, NIH, National Institutes of Health, Building 1 Room 218 
MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, 
[email protected], (301) 496-6837.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The meeting will also be webcast. The draft meeting agenda and 
other information about the SMRB, including information about access 
to the webcast, will be available at http://smrb.od.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: October 15, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-25403 Filed 10-21-09; 8:45 am]
BILLING CODE 4140-01-P